epirubicin has been researched along with Colonic Neoplasms in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (30.00) | 18.7374 |
1990's | 16 (26.67) | 18.2507 |
2000's | 11 (18.33) | 29.6817 |
2010's | 12 (20.00) | 24.3611 |
2020's | 3 (5.00) | 2.80 |
Authors | Studies |
---|---|
Abnous, K; Bayat, P; Dehestani, S; Hashemi, M; Taghdisi, SM; Yazdian-Robati, R | 1 |
Ansari, L; Bagheri, E; Derakhshi, M; Malaekeh-Nikouei, B; Shahtahmassebi, N | 1 |
Brünner, N; Detlefsen, S; Nielsen, SL; Pfeiffer, P; Qvortrup, C; Stenvang, J; Tarpgaard, LS | 1 |
Abnous, K; Alibolandi, M; Ramezani, M; Taghavi, S; Taghdisi, SM | 1 |
Dai, C; Fu, C; Jia, X; Liu, S; Shen, R; Teng, F; Wu, J; Xu, J | 1 |
Liu, Y; Lo, YL; Tsai, JC | 1 |
Abnous, K; Danesh, NM; Ghows, N; Jaafari, MR; Jalalian, SH; Kalat, SA; Lavaee, P; Naghibi, S; Ramezani, M; Shahidi Hamedani, N; Taghdisi, SM; Zandkarimi, M | 1 |
Agama, K; Brünner, N; Doroshow, JH; Jensen, NF; Knudsen, BR; Pfister, TD; Pommier, Y; Roy, A; Rømer, MU; Smith, DH; Stenvang, J; Zhang, HL | 1 |
Abnous, K; Jalalian, SH; Ramezani, M; Taghdisi, SM; Yazdian-Robati, R | 1 |
Dong, S; Sun, ZC; Xiao, XS; Xu, LC; Ye, XD; Yuan, Z | 1 |
Chen, G; Fu, LW; Liang, YJ; Qiu, HB; Yuan, SQ; Zhang, LY; Zhou, ZW | 1 |
Blaskó, G; Nagy, Z; Turcsik, V | 1 |
Bi, F; Lang, N; Liu, M; Liu, Z; Qiu, M; Tang, QL | 1 |
He, JH; Jiang, JW; Liao, XL; Wang, W; Wu, FY; Zhang, XY | 1 |
Chang, YJ; Chen, CH; Huang, YP; Li, ZL | 1 |
Hsu, CY; Lin, HR; Lo, YL | 1 |
Chen, H; Chen, SP; Li, J; Lin, YC; Long, Y; She, ZG; Wu, JH; Yang, B; Zhong, LL; Zhu, X | 1 |
Lo, YL | 1 |
Harao, M; Hishinuma, S; Igarashi, S; Ishihara, M; Jindou, O; Kojima, K; Kotake, K; Matsui, T; Tsukioka, T; Yamamoto, T | 1 |
Ishizuka, D; Kobayashi, K; Ueki, K; Wakakuwa, R | 1 |
Ganzina, F | 1 |
Cartei, G; Ferrazzi, E; Fiorentino, MV; Fornasiero, A; Nicoletto, O; Pappagallo, GL; Refatti, F; Vinante, O | 1 |
Kohsaki, G; Mori, T | 1 |
Ajani, JA; Bodey, GP; Kanojia, MD | 1 |
Wils, JA | 2 |
Kemeny, N; Michaelson, R; Young, C | 1 |
Ferrazzi, E; Fiorentino, MV; Ganzina, F; Maraglino, G; Nicoletto, O; Pagnin, P; Vinante, O | 1 |
Kudo, C; Saito, M; Yoshida, T | 1 |
Hojyo, M; Koizumi, T; Kosaka, A; Maruo, H; Mori, K; Osaku, M; Watahiki, Y | 1 |
Hiraoka, M; Itani, K; Kondo, M; Miura, K; Noguchi, M; Tanaka, Y; Watanabe, N; Yoshikawa, T | 1 |
Abe, R; Hatakeyama, Y; Hoshino, M; Igarashi, W; Koyama, Y; Ohtake, T; Ono, T; Sato, N | 1 |
Czejka, M; Scheithauer, W; Schenk, T | 1 |
Kunii, Y; Mashiko, H; Momono, S; Muto, I; Nakagawa, K; Ouchi, A; Shiiba, K; Wada, M; Yamamoto, K; Yamazaki, T | 1 |
Durante, NM; Eggermont, AM; Kolker, HJ; Loss, WJ; Schellens, JH; Stoter, G; Van de Vrie, W; Verwey, J | 1 |
Awane, Y; Maeshiro, T; Miyamoto, S; Umekita, N | 1 |
Benoit, L; Chauffert, B; Duvillard, C; L'Helgouarc'h, JL | 1 |
Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
Matsuno, S; Ogasawara, T; Suzuki, M; Unno, M; Yamazaki, H; Yoshida, H | 1 |
Azama, T; Furukawa, J; Hashimoto, T; Katsumoto, Y; Nakaguchi, K; Okajima, S; Shingai, T; Sue, F; Takekuni, K; Yukawa, M | 1 |
Binda, MM; Bonfil, RD; Boquete, AL; Ciocca, DR; González, AD; Gude, R; López, GA; Vargas Roig, L | 1 |
Akiyama, N; Ishizaki, M; Motegi, M; Nakajima, M; Osawa, H; Sasamoto, H; Tanaka, S; Wada, W | 1 |
Aronne, T; Caliò, E; Franchi, F; Gargano, L; Pagani Guazzugli Bonaiuti, V; Sbaffi, E; Seminara, P | 1 |
Peng, ZH; Qiu, GQ; Tang, HM; Xing, TH | 1 |
Kouri, MO; Pyrhönen, SO | 1 |
Gilani, S; Huang, SK; Lasic, DD; Martin, FJ; Mayhew, E; Papahadjopoulos, D | 1 |
Babbar, S; Lasic, D; Martin, FJ; Mayhew, EG | 1 |
Allen, TM; Gabizon, A; Huang, SK; Lasic, DD; Lee, KD; Matthay, K; Mayhew, E; Papahadjopoulos, D; Redemann, C; Woodle, MC | 1 |
Bedenne, L; Caillot, D; Chauffert, B; Corda, C; Martin, F; Pelletier, H; Solary, E | 1 |
Maessen, PA; Pinedo, HM; van der Vijgh, WJ | 1 |
Cersosimo, RJ; Hong, WK | 1 |
Angelelli, B; Camaggi, CM; Cola, B; Comparsi, R; Del Prete, P; Franchini, A; Pannuti, F; Rossi, AP; Strocchi, E | 1 |
de Vries, EG; Greidanus, J; Mulder, NH; Nieweg, R; Sleijfer, DT; Verschueren, RC; Willemse, PH | 1 |
Civalleri, D; Muggianu, M; Nobile, MT; Percivale, PL; Razzi, S; Repetto, M; Simoni, G; Tatarek, R; Vidili, MG | 1 |
Aronne, T; Codacci Pisanelli, G; D'Amelio, R; Franchi, F; Manfredi, D; Mulieri, M; Seminara, P | 1 |
Angelelli, B; Camaggi, CM; Comparsi, R; Franchini, A; Pannuti, F; Rossi, AP; Strocchi, E | 1 |
Bresadola, F; Farris, A; Masia, S; Padula, G; Soro, P; Spissu, M; Trignano, M; Virdis, A | 1 |
Gribble, M; Hannigan, JF; Lewis, B; Meyers, FJ; Mitchell, E; Torti, FM; William, L | 1 |
Bruntsch, U; Cavalli, F; Hansen, HH; Holdener, EE; Høst, H; Pinedo, HM; Renard, J; Rozencweig, M | 1 |
Geran, R; Goldin, A; Venditti, JM | 1 |
3 review(s) available for epirubicin and Colonic Neoplasms
Article | Year |
---|---|
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Chemical Phenomena; Chemistry; Colonic Neoplasms; Dogs; Doxorubicin; Epirubicin; Female; Heart; Humans; Kidney Neoplasms; Male; Melanoma; Mutagenicity Tests; Neoplasms, Experimental; Rabbits | 1983 |
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Epirubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental | 1985 |
8 trial(s) available for epirubicin and Colonic Neoplasms
Article | Year |
---|---|
The effect of LMWH (Nadroparin) on tumor progression.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Nadroparin; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Retrospective Studies; Survival Analysis; Time Factors | 2009 |
[Outcomes of effective treatment of cases of metastatic liver tumors by intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Treatment Outcome | 1995 |
[A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Hyperthermia, Induced; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual | 1994 |
[The efficacy of intra-arterial infusion chemotherapy in patients with non-resectable liver metastasis from colorectal cancer--a randomized study comparing FAM versus FEM].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1993 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Phase II study of epirubicin sequential methotrexate and 5-fluorouracil for advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1992 |
Epirubicin in advanced gastrointestinal (GI) cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Esophageal Neoplasms; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Pancreatic Neoplasms; Random Allocation; Rectal Neoplasms; Stomach Neoplasms | 1986 |
49 other study(ies) available for epirubicin and Colonic Neoplasms
Article | Year |
---|---|
Smart delivery of epirubicin to cancer cells using aptamer-modified ferritin nanoparticles.
Topics: Cell Line, Tumor; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Epirubicin; Ferritins; Humans; Nanoparticles | 2022 |
Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells.
Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Durapatite; Epirubicin; Female; Folic Acid; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Particle Size; Polyethylene Glycols; Porosity | 2020 |
New use for old drugs: Epirubicin in colorectal cancer.
Topics: Colonic Neoplasms; Colorectal Neoplasms; Epirubicin; Humans; Pharmaceutical Preparations | 2021 |
Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Topics: Adsorption; Animals; Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Survival; Chitosan; CHO Cells; Colonic Neoplasms; Cricetulus; Drug Carriers; Drug Compounding; Drug Liberation; Epirubicin; Female; Humans; Lactic Acid; MCF-7 Cells; Mice, Inbred BALB C; Mucin-1; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Tumor Burden | 2017 |
Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biomarkers, Tumor; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Computational Biology; Databases, Genetic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Paclitaxel; RNA, Long Noncoding | 2018 |
Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Area Under Curve; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Half-Life; Liposomes; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Oligonucleotides, Antisense; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2013 |
Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Line, Tumor; CHO Cells; Colonic Neoplasms; Cricetinae; Cricetulus; Diagnostic Imaging; Epirubicin; Ferric Compounds; Humans; Magnetic Phenomena; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mucin-1; Nanoparticles | 2013 |
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Topics: Benzodioxoles; Binding Sites; Camptothecin; Cell Line, Tumor; Chromosome Deletion; Colonic Neoplasms; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Gene Dosage; Guanidines; HCT116 Cells; HT29 Cells; Humans; Hydrazones; Irinotecan; Isoquinolines; Mutation | 2016 |
Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo.
Topics: Animals; Aptamers, Nucleotide; Breast Neoplasms; Cell Line; Cell Line, Tumor; CHO Cells; Colonic Neoplasms; Cricetulus; Drug Delivery Systems; Drug Liberation; Epirubicin; Female; Humans; MCF-7 Cells; Mice | 2016 |
[Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cisplatin; Colonic Neoplasms; Diffusion Magnetic Resonance Imaging; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Predictive Value of Tests; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2009 |
[Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cisplatin; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Female; Fluorouracil; Genes, MDR; Humans; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; RNA, Messenger | 2009 |
Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
Topics: AC133 Antigen; Antibiotics, Antineoplastic; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Glycoproteins; Humans; Hyaluronan Receptors; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Peptides; Vincristine | 2010 |
[Knock-down of apollon gene by antisense oligodeoxynucleotide inhibits the proliferation of Lovo cells and enhances chemo-sensitivity].
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colonic Neoplasms; Epirubicin; Fluorouracil; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Oligodeoxyribonucleotides, Antisense; RNA, Messenger; Sensitivity and Specificity; Transfection | 2011 |
GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Down-Regulation; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Epirubicin; Gene Silencing; Heat-Shock Proteins; Humans; NF-E2-Related Factor 2; Oxidative Stress; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction | 2012 |
pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug.
Topics: Acrylic Resins; Adenocarcinoma; Administration, Oral; Animals; Antibiotics, Antineoplastic; Area Under Curve; Biological Availability; Colonic Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Epirubicin; Half-Life; Hydrogels; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Poloxamer; Rats; Rats, Sprague-Dawley; Temperature | 2013 |
Synthesis and antitumor activities of derivatives of the marine mangrove fungal metabolite deoxybostrycin.
Topics: Anthraquinones; Antineoplastic Agents; Ascomycota; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Epirubicin; Female; HCT116 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms | 2012 |
A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells.
Topics: Adenocarcinoma; Caco-2 Cells; Caspases; Cell Death; Cell Proliferation; Colonic Neoplasms; DNA Fragmentation; Drug Synergism; Epirubicin; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Isoflavones; Membrane Potential, Mitochondrial; Models, Biological; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2012 |
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization].
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Colonic Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Humans; Immunohistochemistry; Iodized Oil; Liver Neoplasms; Middle Aged | 2002 |
[Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colon, Sigmoid; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Sigmoid Neoplasms | 2005 |
Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1984 |
[Diagnosis of cancer using lymphocyte electrophoresis (2)].
Topics: Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Electrophoresis; Epirubicin; Female; Humans; Lymphocytes; Male; Membrane Potentials; Middle Aged; Neoplasms; Rectal Neoplasms; Stomach Neoplasms | 1984 |
Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Middle Aged; Rectal Neoplasms; Stereoisomerism | 1984 |
Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Sigmoid Neoplasms | 1984 |
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Fatigue; Humans; Leukopenia; Middle Aged; Nausea; Rectal Neoplasms; Stereoisomerism; Vomiting | 1982 |
Phase II study of 4'epi-doxorubicin.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Male; Melanoma; Middle Aged; Neoplasms; Sarcoma | 1982 |
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
Topics: Colonic Neoplasms; Drug Resistance; Epirubicin; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Rectal Neoplasms; Verapamil | 1993 |
Modulation of multidrug resistance with dexniguldipine hydrochloride (B8509-035) in the CC531 rat colon carcinoma model.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Colonic Neoplasms; Dihydropyridines; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Male; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Tumor Cells, Cultured | 1996 |
[Evaluation of hepatic resection and hepatic arterial infusion chemotherapy for multiple liver metastases from colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1997 |
[Intratumoral chemotherapy in an experimental animal model: another therapeutic possibility in cancerology].
Topics: Amiodarone; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cisplatin; Colonic Neoplasms; Coloring Agents; Data Interpretation, Statistical; Enzyme Inhibitors; Epirubicin; Female; Fluorouracil; Infusions, Intra-Arterial; Infusions, Intravenous; Injections, Intralesional; Male; Melphalan; Mitomycins; Neoplasm Transplantation; Rats; Time Factors; Tumor Cells, Cultured | 1999 |
[A study of liver metastasis from colorectal cancer in which hepatic resection was performed after hepatic arterial infusion chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms | 2000 |
[Repetitive chemo-embolization with degradable starch microspheres (DSM) to each left and replaced right hepatic artery in a patient with multiple liver metastases of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colonic Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Mesenteric Artery, Superior; Microspheres; Middle Aged; Mitomycin; Starch | 2000 |
Differential anthracycline sensitivity in two related human colon carcinoma cell lines expressing similar levels of P-glycoprotein.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Survival; Colonic Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Immunohistochemistry; Molecular Chaperones; Neoplasm Proteins; Tumor Cells, Cultured | 2001 |
[Long-term survival of a patient with postoperative liver metastasis of stage IVa gallbladder cancer responding to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Duodenal Neoplasms; Epirubicin; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin | 2001 |
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Colonic Neoplasms; Drug Interactions; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Dyes; Fluorouracil; Humans; Rhodamines; Tumor Cells, Cultured | 2001 |
Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cisplatin; Colonic Neoplasms; Epirubicin; Fas Ligand Protein; fas Receptor; Flow Cytometry; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Membrane Glycoproteins; Mitomycins; Tumor Cells, Cultured | 2001 |
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
Topics: Animals; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Liposomes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Tissue Distribution | 1992 |
Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid.
Topics: Animals; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Resistance; Epirubicin; Female; Liposomes; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred Strains | 1992 |
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
Topics: Animals; Colonic Neoplasms; Doxorubicin; Drug Carriers; Drug Stability; Epirubicin; Female; Gallium Radioisotopes; Liposomes; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Tissue Distribution | 1991 |
Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Colonic Neoplasms; Drug Resistance; Drug Synergism; Epirubicin; In Vitro Techniques; Quinidine; Quinine; Rats; Verapamil | 1990 |
Comparative metabolism and pharmacokinetics of doxorubicin and 4'-epidoxorubicin in plasma, heart and tumor of tumor-bearing mice.
Topics: Animals; Chromatography, High Pressure Liquid; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Half-Life; Mice; Mice, Inbred BALB C; Myocardium | 1990 |
Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administration.
Topics: Adult; Carcinoma, Hepatocellular; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Injections, Intraperitoneal; Kinetics; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms | 1985 |
Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
Topics: Adult; Aged; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Rectal Neoplasms | 1988 |
Interim results of intra-arterial 4'-epi-doxorubicin for liver metastases.
Topics: Adult; Aged; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Stereoisomerism | 1988 |
Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary results.
Topics: Colonic Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Epirubicin; Humans; In Vitro Techniques; Liver Neoplasms; Rectal Neoplasms; RNA, Neoplasm | 1987 |
Intrahepatic arterial administration of 4'epidoxorubicin (epirubicin) in advanced cancer patients. A pharmacokinetic study.
Topics: Aged; Colonic Neoplasms; Doxorubicin; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kinetics; Liver Neoplasms; Middle Aged; Rectal Neoplasms | 1986 |
[Prevention of hepatic metastasis in patients operated on for colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Epirubicin; Fluorouracil; Humans; Liver Neoplasms; Rectal Neoplasms | 1987 |
Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Topics: Adult; Aged; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Leukocyte Count; Middle Aged; Neoplasm Metastasis; Platelet Count; Rectal Neoplasms | 1985 |
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Rectal Neoplasms; Vomiting | 1985 |